Inlägg av Maria Rankka

Gunnar Forssell, former strategy lead at Merck, joins Takura

Takura is happy to strengthen its core team with Gunnar Forssell who will join towards the end of August as Executive Vice President Strategic Planning. Gunnar will also become the executive chairman of Takura’s immuno-onkology company CuraCell. Gunnar has extensive experience from senior positions in the pharmaceutical industry globally. His most recent job was as Executive Director […]

Takura acquires Polybiocept GmbH

Takura has acquired all shares in clinical stage immuno-oncology company Polybiocept GmbH (PBC). Takura was already a minority owner in the company which owns a patent portfolio for TIL (tumor infiltrating lymphocytes) therapy. Immunotherapy is one of the fastest growing segments in the pharmaceutical industry and has the potential to revolutionize cancer care. PBC has […]